Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Shares Issued (2019 - 2025)

Historic Shares Issued for Benitec Biopharma (BNTC) over the last 6 years, with Q2 2025 value amounting to $1000.0.

  • Benitec Biopharma's Shares Issued fell 9999.75% to $1000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $40.0 million, marking a year-over-year decrease of 4356.76%. This contributed to the annual value of $30.5 million for FY2025, which is 5702.78% down from last year.
  • According to the latest figures from Q2 2025, Benitec Biopharma's Shares Issued is $1000.0, which was down 9999.75% from $40.0 million recorded in Q2 2024.
  • Benitec Biopharma's Shares Issued's 5-year high stood at $40.0 million during Q2 2024, with a 5-year trough of -$39000.0 in Q1 2024.
  • In the last 5 years, Benitec Biopharma's Shares Issued had a median value of $7.1 million in 2021 and averaged $12.9 million.
  • Per our database at Business Quant, Benitec Biopharma's Shares Issued surged by 7268.51% in 2023 and then crashed by 9999.75% in 2025.
  • Over the past 5 years, Benitec Biopharma's Shares Issued (Quarter) stood at $14.3 million in 2021, then rose by 25.48% to $17.9 million in 2022, then crashed by 99.78% to $39000.0 in 2023, then skyrocketed by 102464.1% to $40.0 million in 2024, then plummeted by 100.0% to $1000.0 in 2025.
  • Its Shares Issued stands at $1000.0 for Q2 2025, versus $40.0 million for Q2 2024 and -$39000.0 for Q1 2024.